Home Cart Sign in  
Chemical Structure| 138199-71-0 Chemical Structure| 138199-71-0

Structure of Levofloxacin hydrate
CAS No.: 138199-71-0

Chemical Structure| 138199-71-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Levofloxacin Hemihydrate is antibiotic against gram-negative organisms, working by inhibiting the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Synonyms: Levofloxacin hemihydrate; Levaquin hydrate; Cravit hydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Levofloxacin hydrate

CAS No. :138199-71-0
Formula : C36H42F2N6O9
M.W : 740.75
SMILES Code : O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[H]O[H].O=C(C(C5=O)=CN6[C@@H](C)COC7=C(N8CCN(C)CC8)C(F)=CC5=C67)O
Synonyms :
Levofloxacin hemihydrate; Levaquin hydrate; Cravit hydrate
MDL No. :MFCD07772024
InChI Key :SUIQUYDRLGGZOL-RCWTXCDDSA-N
Pubchem ID :3033924

Safety of Levofloxacin hydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H317-H334-H361-H362
Precautionary Statements:P201-P202-P260-P263-P264-P270-P272-P280-P284-P301+P312+P330-P302+P352-P304+P340-P308+P313-P333+P313-P405-P501

Isoform Comparison

Biological Activity

Target
  • Topo II

In Vitro:

Cell Line
Concentration Treated Time Description References
ZF4 cells 1 × 10^6 CFU/ml 3 hours To test the effect of Lev-S and Lev-R V. alginolyticus on promoter activity in ZF4 cells PMC7264874
Mycobacterium tuberculosis H37Ra (extracellular) 0.125 mg/L (1xMIC) 7 days To evaluate the bactericidal effect of levofloxacin against extracellular Mycobacterium tuberculosis. Results showed maximal kill (Emax) >7 log10 CFU/mL. PMC6260169
THP-1 cells 0.125 mg/L (1xMIC) 7 days To evaluate the bactericidal effect of levofloxacin against intracellular Mycobacterium tuberculosis. Results showed that the killing effect was 2 log10 CFU/mL lower than against extracellular bacilli. PMC6260169
Elizabethkingia anophelis 0.5 to 128 mg/L 72 hours To determine the minimum inhibitory concentration (MIC) and mutant prevention concentration (MPC) of levofloxacin against Elizabethkingia anophelis and investigate its resistance mechanisms PMC9295545
Stenotrophomonas maltophilia K M6 LEVr 8 μg/ml Determine the MIC of K M6 LEVr against Levofloxacin PMC7927820
Stenotrophomonas maltophilia K M7 8 μg/ml Determine the MIC of K M7 against Levofloxacin PMC7927820
Stenotrophomonas maltophilia K M6 4 µg/ml Determine the MIC of K M6 against Levofloxacin PMC7927820
Stenotrophomonas maltophilia K279a 2 µg/ml Determine the MIC of K279a against Levofloxacin PMC7927820

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Zebrafish (Danio rerio) Zebrafish infection model Intramuscular injection 9 × 10^5 CFU/fish Single injection, observed for 6 days To evaluate the differences in pathogenicity and immunogenicity between Lev-R and Lev-S V. alginolyticus in zebrafish PMC7264874

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.14mL

6.75mL

1.35mL

0.68mL

13.50mL

2.70mL

1.35mL

References

 

Historical Records

Categories